Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -12.39% vs 5.66% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -30.47% vs -10.75% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -14.98% vs 5.98% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 90.48% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of JiangXi Tianxin Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -19.08% vs 4.40% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -12.39% vs 5.66% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -37.15% vs 39.50% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -30.47% vs -10.75% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -36.58% vs 48.17% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.98% vs 5.98% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 90.48% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






